Millions of US women are affected by the systemic skeletal disorder osteoporosis. As the population of aging female patients continues to rise, so do the medical and economic burdens of osteoporotic fracture. Thus, the time has arrived for both aggressive management and enhanced prevention of this disease in women of all ages.
TO OUR READERS...
Millions of US women are affected by the systemic skeletal disorder osteoporosis. As the population of aging female patients continues to rise, so do the medical and economic burdens of osteoporotic fracture. Thus, the time has arrived for both aggressive management and enhanced prevention of this disease in women of all ages.
Early detection of bone breakdown is an important element of effective osteoporosis intervention. Although bone mineral density (BMD) has long been used as a marker for disease progression, alterations in the microarchitecture of bone equal or exceed BMD in importance. This distinction is necessary in measuring the effectiveness of antiosteoporotic interventions, as even seemingly minor increases in BMD have a significant impact on fracture risk. A thorough understanding of the available treatment options, including their mechanisms of action, usefulness in various patient populations, and compliance rates, is also critical to the success of osteoporosis management.
The body of research supporting osteoporosis risk factors and prevention is growing every year, indicating that patients should be educated on bone maintenance from an early age. Good nutrition and various other lifestyle habits are indeed advantageous for bone, and women can use them to help maintain skeletal integrity and help counteract nonmodifiable risk factors (eg, ethnicity, family history).
We at THE FEMALE PATIENT® welcome you to this special edition, the third in a series focusing on innovations in osteoporosis. We hope that you find its contents enlightening and useful in the everyday practice of female health care.
Articles:
Fasting glucose at GDM diagnosis may predict postpartum glucose abnormalities
February 6th 2025A recent study suggests that elevated fasting glucose levels at the time of gestational diabetes diagnosis could be an early indicator of postpartum glucose intolerance, emphasizing the need for close monitoring after delivery.
Read More
Ulipristal plus misoprostol shows promise for medication abortion
February 5th 2025A recent study found that ulipristal acetate followed by misoprostol is a safe, effective, and acceptable option for medication abortion, offering a potential alternative in areas with limited access to mifepristone.
Read More
Identification and management of patients at increased risk for breast cancer
February 5th 2025With breast cancer being the most diagnosed invasive cancer in the United States, OB-GYN practitioners play a crucial role in identifying high-risk patients and guiding them through screening, prevention, and risk-reduction strategies.
Read More